Novel Corona Virus (SARS-CoV-2) Antigen Rapid Test

Rapid chromatographic immunoassay (lateral-flow) for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in nasopharyngeal swabs from individuals who are suspected of COVID-19 within the first seven days from the onset of symptoms.

(Catalog Number : SC30107W)

Principle : Rapid chromatographic immunoassay/Lateral-flow assay

Automation : No

Approvals : CE-IVD

Suitability : Detection of SARS-CoV-2 nucleocapsid antigens in nasopharyngeal swabs from individuals who are suspected of COVID-19 within the first seven days from the onset of symptoms.

Capital equipment required : No

Key Points :

• Fast: results within 15 minutes
• Easy to use: 3 steps to finish the test
• Complete: all necessary components provided
• Safe: swab in protective packaging to avoid biohazard
• Quality Control: ensures the result is reliable
• Clinical Sensitivity: 96.7%
• Clinical Specificity: 97.9%
• Limit of Detection: 1.0 x 102 TCID50/mL
• Sample type: nasal/nasopharyngeal swabs
• Storage temperature: 4 - 30oC
• Transportation temperature: -20 - 45oC
• Package: 20 or 50 Tests per box